Scientific Advisory Board Member
David Feldman, MD is Emeritus Professor of Medicine (Active) at Stanford University School of Medicine where he was chief of the Endocrinology Division for 10 years. He has been director of the Endocrinology, Diabetes and Aging Training Grant for 15 years. His clinical expertise is in the treatment of a wide variety of endocrine diseases with a special interest in osteoporosis, bone and mineral metabolism and metabolic bone disease. His current major research focus is hormone dependent cancer including prostate cancer and breast cancer. His laboratory focuses on the role of steroid hormone receptors, particularly the vitamin D receptor the androgen receptor and the estrogen receptor, in the mechanism of action of hormones and their roles in breast and prostate cancer. His basic science research interests include the mechanisms of vitamin D, androgen, and estrogen action. He is actively involved in clinical trials studying the use of vitamin D in prostate and breast cancer. Dr. Feldman is a member of several prestigious scientific societies and was recently honored with an award for a career of outstanding contributions to vitamin D research by the Vitamin D Workshop. He reviews for and has served on the editorial boards of multiple medical and scientific journals, and has been a member of many national grant review panels. Dr. Feldman has authored over 250 medical research articles, reviews, editorials, and book chapters. He is the editor-in-chief of “Vitamin D”, now in preparation for its third edition and is an editor of the first, second and third editions “Osteoporosis”. Both books are considered the major texts in their field. Dr. Feldman has consulted for and has served on the scientific advisory board of several biotech companies.